J E Dancey1. 1. Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
Authors: Seema Bhatlekar; Sankar Addya; Moreh Salunek; Christopher R Orr; Saul Surrey; Steven McKenzie; Jeremy Z Fields; Bruce M Boman Journal: Stem Cells Dev Date: 2013-11-05 Impact factor: 3.272
Authors: Irene M Ghobrial; Morie Gertz; Betsy Laplant; John Camoriano; Suzanne Hayman; Martha Lacy; Stacey Chuma; Brianna Harris; Renee Leduc; Meghan Rourke; Stephen M Ansell; Daniel Deangelo; Angela Dispenzieri; Leif Bergsagel; Craig Reeder; Kenneth C Anderson; Paul G Richardson; Steven P Treon; Thomas E Witzig Journal: J Clin Oncol Date: 2010-02-08 Impact factor: 44.544
Authors: Craig C Hofmeister; Xiaoxia Yang; Flavia Pichiorri; Ping Chen; Darlene M Rozewski; Amy J Johnson; Seungsoo Lee; Zhongfa Liu; Celia L Garr; Erinn M Hade; Jia Ji; Larry J Schaaf; Don M Benson; Eric H Kraut; William J Hicks; Kenneth K Chan; Ching-Shih Chen; Sherif S Farag; Michael R Grever; John C Byrd; Mitch A Phelps Journal: J Clin Oncol Date: 2011-08-08 Impact factor: 44.544
Authors: Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial Journal: Blood Date: 2007-08-30 Impact factor: 22.113